The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a value of USD 35.8 Billion by 2030 at a CAGR (Compound Annual Growth Rate) of 11 ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Anti-Microbial/Anti-Fungal Tests MarketThe global anti-microbial/anti-fungal tests market is poised for significant growth, ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5% ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Gov. Greg Abbott, in the middle of his third term with an eye on a fourth, is challenging the Texas Legislature with an ambitious 2025 to-do list beginning with enacting the school voucher program ...

President Trump on Wednesday met with California Gov. Gavin Newsom (D) and Texas Gov. Greg Abbott (R) at the White House to discuss fire recovery and border security efforts. The Golden State was ...